SNTI - Balance Sheet - Senti Biosciences, Inc.

Current Liabilities	13.1 M
Accounts Payable	1.45 M
Short-Term Debt	0
Other Current Liabilities	11.7 M
Non-Current Liabilities	33.9 M
Long-Term Debt	0
Other Non-Current Liabilities	33.9 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	48.3	35.9	57.6	56.0	30.5	5.3
Short Term Investments	0	0	40.9	1.2	25 K	12.5
Receivables	1.8	17.7	0.6	0.5	0.3	78 K
Inventory	0.3	0	3.3	2.6	25 K	0
Other Current Assets	8.5	17.6	3.4	3.7	0.9	0.9
Total Current Assets	59.0	71.2	102.6	60.2	31.7	18.8
PP&E	35.2	41.6	74.6	33.1	16.1	16.6
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	4.6	3.4	3.3	0	0
Other Long Term Assets	3.6	2.0	0.3	0.2	0.5	(16.6)
Other Assets	0	0	0	0	0	0.5
Total Assets	97.8	119.5	180.8	96.7	48.3	35.8
LIABILITIES
Accounts Payable	1.5	1.2	1.4	5.2	0.9	1.2
Short Term Debt	0	4.1	4.0	1.7	1.5	0
Other Current Liabilities	11.0	6.3	11.9	6.0	2.4	3.1
Total Current Liabilities	13.1	12.7	18.1	14.5	4.9	4.3
Long Term Debt	0	33.5	35.1	21.0	12.5	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	33.9	6.4	0.4	172.5	89.7	0
Total Liabilities	72.2	52.6	53.5	208.2	107.1	17.9
EQUITY
Common Stock	1 K	5 K	4 K	1 K	1 K	1 K
Retained Earnings	(297.1)	(244.3)	(173.3)	(115.1)	(59.8)	(39.9)
Other Accumulative Comprehensive Income/Loss	0	0	1 K	(171.8)	(89.7)	0
Total Equity	25.6	66.9	127.3	(111.5)	(58.7)	18.0
Total Liabilities and Equity	97.8	119.5	180.8	96.7	48.3	0
SHARES OUTSTANDING
Common Shares Outstanding	4.6	4.4	4.4	4.4	4.4	1.4

Free